Akzo Nobel NV
AKZA: XAMS (NLD)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
€87.00 | Yrdxgx | Mbgdrgm |
AkzoNobel Delivers Sharp Growth in Q2 but Earnings Miss Expectations; Shares Fairly Valued
Narrow-moat AkzoNobel reported second-quarter EBIT of EUR 335 million, up 41% over 2020 but missing the Visible Alpha consensus. Profits were negatively impacted by sharply rising raw material inflation, leading to margins below consensus. For the full year, we were already below consensus and don’t expect to make any material changes to our forecast or EUR 99 fair value estimate based on second-quarter results. At current levels, the shares look fairly valued.